Profile of Nagoya University Hospital 2012

• Idea/Basic Decision
• Declaration Regarding Patients' Rights and Responsibilities
• Message From the Director

• Idea, Basic Decision, History
• Organization Chart of University Hospital
• Organization Chart of Administration Office
• Chronological List of Directors of University Hospital
• Established Date of Clinical Departments
• Clinical Departments
• Legal Authorization of Medical Services
• University Hospital Staff, Number of Staffs
• Number of Beds
• Patient Services in the University Hospital in 2011
• Clinical Indicator
• Access

Hematology

Director NAOE, Tomoki (Professor)   3W · 12E

Challenge intractable blood diseases with advanced clinical techniques

We provide the best medical care for blood diseases requiring high expertise as well as promote the development of new diagnostic and therapeutic techniques.

Medical Care System

Our department has four dispensaries, 35 beds for inpatients (of which 10 are bioclean beds), and 10 to 15 staff always on duty to provide expert medical care. Every effort is made to develop new diagnostic and therapeutic techniques and to conduct high-quality clinical research to establish evidence based medicine (EBM).

Target Diseases

We provide medical care to patients with hematological disorders including malignant diseases, such as leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes (MDS), and hemorrhagic diseases such as hemophilia and Von Willebrand's disease.

Strong Fields

In the therapeutic field of hematopoietic malignancies, we provide the best possible treatment based on informed consent consisting mainly of standard chemotherapies. In addition, we are actively involved in clinical studies and the development of new therapies such as molecular targeting therapies, and the development of new hematopoietic stem cell transplantation processes.

Clinical Results

We aim to provide medical care of the highest quality, safety and satisfaction. We accept more than 50 new patients with hematopoietic tumors, perform more than 20 hematopoietic stem cell transplantations, and provide medical care to more than 400 patients with congenital hemorrhagic diseases per year.

Specialized Outpatient Clinic

We provide medical care at the "specialized outpatient hemophilia clinic", which is responsible for comprehensive medical care for patients with hemorrhagic disease such as hemophilia and Von Willebrand's disease and at "outpatient transplant donor clinic" for follow-up of hematopoietic stem cell transplant donors.

Advanced Medicine and Research

Our department is involved in basic research on topics such as maintenance and disorder of the hematopoietic system and in the development of a wide range of advanced clinical techniques including molecular targeting therapies, clinical application of transplantation and regenerative medicine, and control of thrombosis.